codebreak100: assessing sotorasib in patients with kras p.g12c-mutant pancreatic cancer
Published 2 years ago • 318 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
6:28
codebreak 100: sotorasib in kras-mutated nsclc
-
2:52
kras-mutant nsclc: codebreak 100 trial of sotorasib
-
2:32
codebreak 100: patient-reported outcomes evaluating sotorasib in kras p.g12c mnsclc
-
5:22
codebreak100 trial: evaluating sotorasib in pretreated kras p.g12c mnsclc
-
5:26
asco 2021 lung recap: codebreak 100: sotorasib in kras g12c mutation
-
3:01
phase ii codebreak 100 trial of sotorasib in advanced nsclc
-
2:29
sotorasib achieved clinically meaningful activity in kras g12c-mutated advanced pancreatic cancer
-
1:26
krystal-1 and codebreak 100: targeting kras g12c in lung cancer
-
0:51
personalized treatment approaches for patients with kras-mutant pancreatic cancer
-
2:24
overall survival in the phase ii codebreak 100 trial in nsclc
-
2:42
assessing the heterogeneity of kras-mutant pancreatic adenocarcinomas
-
1:58
codebreak100: detecting mechanisms of intrinsic resistance by ctdna
-
0:41
improving outcomes in kras-mutant pancreatic cancer
-
2:42
codebreak 200: sotorasib versus docetaxel in pretreated kras g12c-mutant nsclc
-
0:35
data on kras inhibitors in lung cancer at wclc 2022
-
1:10
current treatment strategies krasg12c–mutated nsclc
-
0:57
sotorasib: first targeted approval for kras g12c mutated nsclc
-
7:19
safety of sotorasib and panitumumab in advanced kras p.g12c-mutated colorectal cancer
-
0:58
kras g12c inhibitors for gi cancer